← All trials
NCT04646317
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 30, 2020
- Primary completion
- Mar 2, 2021
- Completion date
- Mar 2, 2021
- First posted
- Nov 27, 2020
- Last posted
- Dec 22, 2020
- Enrollment
- 44
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Dr. Ruth K.M. Pfau Civil Hospital, KarachiLead sponsor
- Dow University of Health SciencesOverall official - principal investigator
- Dr. Ruth K.M. Pfau Civil Hospital, KarachiReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.